Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

European Journal of Neuroscience

Volumn 20, Issue 5, 2004, Pages 1255-1266

  Robelet, S ^a   Melon, C ^a   Guillet, B ^a   Salin, P ^a   Kerkerian Le Goff, L ^a  

^a CNRS   (France)

Author keywords

Basal ganglia; GLT1; Glutamate; L DOPA; Microdialysis; Parkinson's disease

Indexed keywords

GLUTAMATE TRANSPORTER; GLUTAMIC ACID; LEVODOPA; OXIDOPAMINE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; BRAIN INJURY; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DYSKINESIA; GENE EXPRESSION; GENE OVEREXPRESSION; IN SITU HYBRIDIZATION; LONG TERM CARE; MALE; MEASUREMENT; MICRODIALYSIS; NONHUMAN; PARAMETER; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

ANIMALS; BASAL GANGLIA; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID TRANSPORTER 2; EXTRACELLULAR FLUID; GENE EXPRESSION REGULATION; GLUTAMIC ACID; LEVODOPA; MALE; PARKINSON DISEASE; RATS; RATS, WISTAR;

EID: 4544347756     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03591.x     Document Type: Article

References (51)

1. Abarca, J., Gysling, K., Roth, R.H. & Bustos, G. (1995) Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies. Neurochem. Res., 20, 159-169.
2. Baas, H. (2000) Dyskinesia in Parkinson's disease. Pathophysiology and clinical risk factors. J. Neurol., 247, IV/12-IV/16.
3. Baker, D.A., Xi, Z.X., Shen, H., Swanson, C.J. & Kalivas, P.W. (2002) The origin and neuronal function of in vivo nonsynaptic glutamate. J. Neurosci., 22, 9134-9141.
4. Bellocchio, E.E., Hu, H., Pohorille, A., Chan, J., Pickel, V.M. & Edwards, R.H. (1998) The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J. Neurosci., 18, 8648-8659.
5. Bianchi, L., Galeffi, F., Bolam, J.P. & Della Corte, L. (2003) The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis. Eur. J. Neurosci., 18, 856-868.
6. Biggs, C.S., Fowler, L.J., Whitton, P.S. & Starr, M.S. (1997) Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway? Brain Res., 753, 163-175.
7. Biggs, C.S. & Starr, M.S. (1997) Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra. Neurosci. Biobehav. Rev., 21, 497-504.
8. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
9. Calabresi, P., Mercuri, N.B., Sancesario, G. & Bernard, G. (1993) Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain, 116, 433-452.
10. Calon, F. & Di Paolo, T. (2002) Levodopa response motor complications - GABA receptors and preproenkephalin expression in human brain. Parkinsonism Relat. Disord., 8, 449-454.
11. Calon, F., Grondin, R., Morissette, M., Goulet, M., Blanchet, P.J., Di Paolo, T. & Bedard, P.J. (2000) Molecular basis of levodopa-induced dyskinesias. Ann. Neurol., 47, 70-78.
12. Calon, F., Morissette, M., Ghribi, O., Goulet, M., Grondin, R., Blanchet, P.J., Bedard, P.J. & Di Paolo T. (2002) Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated monkeys following dopamine agonist treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry, 26, 127-138.
13. Carlsson, M. & Carlsson, A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci., 13, 272-276.
14. Cenci, M.A., Lee, C.S. & Bjorklund, A. (1998) L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci., 10, 2694-2706.
15. Chase, T.N., Oh, J.D. & Konitsiotis, S. (2000) Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms. J. Neurol., 247, 36-42.
16. Cheng, N., Maeda, T., Kume, T., Kaneko, S., Kochiyama, H., Akaike, A., Goshima, Y. & Misu, Y. (1996) Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res., 743, 278-283.
17. Corsi, C., Pinna, A., Gianfriddo, M., Melani, A., Morelli, M. & Pedata, F. (2003) Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. Eur. J. Pharmacol., 464, 33-38.
18. Danbolt, N.C. (2001) Glutamate uptake. Prog. Neurobiol., 65, 1-105.
19. Del Arco, A., Segovia, G., Fuxe, K. & Mora, F. (2003) Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J. Neurochem., 85, 23-33.
20. Di Cara, B., Dusticier, N., Forni, C., Lievens, J.C. & Daszuta, A. (2001) Serotonin depletion produces long lasting increase in striatal glutamatergic transmission. J. Neurochem., 78, 240-248.
21. Dringen, R. & Hirrlinger, J. (2003) Glutathione pathways in the brain. Biol. Chem., 384, 505-516.
22. Gubellini, P., Picconi, B., Bari, M., Battista, N., Calabresi, P., Centonze, D., Bernardi, G., Finazzi-Agro, A. & Maccarrone, M. (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J. Neurosci., 22, 6900-6907.
23. Henry, B., Crossman, A.R. & Brotchie, J.M. (1999) Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Exp. Neurol., 155, 204-220.
24. Herrera-Marschitz, M., You, Z.B., Goiny, M., Meana, J.J., Silveira, R., Godukhin, O.V., Chen, Y., Espinoza, S., Pettersson, E., Loidl, C.F., Lubec, G., Andersson, K., Nylander, I., Terenius, L. & Ungerstedt, U. (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J. Neurochem., 66, 1726-1735.
25. Herzog, E., Bellenchi, G.C., Gras, C., Bernard, V., Ravassard, P., Bedet, C., Gasnier, B., Giros, B. & El Mestikawy, S. (2001) The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J. Neurosci., 21, RC181.
26. Hirsch, E.C., Perier, C., Orieux, G., Francois, C., Feger, J., Yelnik, J., Vila, M., Levy, R., Tolosa, E.S., Marin, C., Trinidad Herrero, M., Obeso, J.A. & Agid, Y. (2000) Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci., 23, 78-85.
27. Ingham, C.A., Hood, S.H., Taggart, P. & Arbuthnott, G.W. (1998) Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J. Neurosci., 18, 4732-4743.
28. Jabaudon, D., Shimamoto, K., Yasuda-Kamatani, Y., Scanziani, M., Gahwiler, B.H. & Gerber, U. (1999) Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. Proc. Natl. Acad. Sci. USA, 96, 8733-8738.
29. 3H]-mazindol autoradiography. J. Neurosci., 5, 1513-1521.
30. Jonkers, N., Sarre, S., Ebinger, G. & Michotte, Y (2002) MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats. Brain Res., 926, 149-155.
31. Kerkerian, L., Dusticier, N. & Nieoullon, A. (1987) Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum. J. Neurochem., 48, 1301-1306.
32. Lievens, J.C., Salin, P., Nieoullon, A. & Kerkerian-Le Goff, L. (2001) Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum. J. Neurochem., 79, 893-902.
33. Lindefors, N. & Ungerstedt, U. (1990) Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci. Lett., 115, 248-252.
34. Luo, J., Kaplitt, M.G., Fitzsimons, H.L., Zuzga, D.S., Liu, Y., Oshinsky, M.L. & During, M.J. (2002) Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science, 298, 425-429.
35. Maeda, T., Cheng, N., Kume, T., Kaneko, S., Kouchiyama, H., Akaike, A., Ueda, M., Satoh, M., Goshima, Y. & Misu, Y. (1997) L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons. Brain Res., 771, 159-162.
36. Marin, C., Jimenez, A., Bonastre, M., Vila, M., Agid, Y., Hirsch, E.C. & Tolosa, E. (2001) LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats. Synapse, 42, 40-47.
37. Marti, M., Sbrenna, S., Fuxe, K., Bianchi, C., Beani, L. & Morari, M. (1999) In vitro evidence for increased facilitation of striatal acetylcholine release via pre- and postsynaptic NMDA receptors in hemiparkinsonian rats. J. Neurochem., 72, 875-878.
38. Meshul, C.K., Emre, N., Nakamura, C.M., Allen, C., Donohue, M.K. & Buckman, J.F. (1999) Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience, 88, 1-16.
39. van Muiswinkel, F.L., Riemers, F.M., Peters, G.J., LaFleur, M.V., Siegel, D., Jongenelen, C.A. & Drukarch, B. (2000) L-DOPA stimulates expression of the antioxidant enzyme NAD(P)H: quinone oxidoreductase (NQO) in cultured astroglial cells. Free Radic. Biol. Med., 29, 442-453.
40. Olanow, C.W. & Obeso, J.A. (2000) Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors. Neurology, 55, S72-S77; discussion, S78-81.
41. Papa, S.M. & Chase, T.N. (1996) Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann. Neurol., 39, 574-578.
42. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
43. Perier, C., Marin, C., Bonastre, M., Tolosa, E. & Hirsch, E.C. (2002) AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with 1-dopa. Eur. J. Neurosci., 16, 2236-2240.
44. Picconi, B., Centonze, D., Hakansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M.A. & Calabresi, P. (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci., 6, 501-506.
45. Pines, G., Danbolt, N.C., Bjoras, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm-Mathisen, J., Seeberg, E. & Kanner, B.I. (1992) Cloning and expression of a rat brain 1-glutamate transporter. Nature, 360, 464-467.
46. Re, D.B., Boucraut, J., Samuel, D., Birman, S., Kerkerian-Le Goff, L. & Had-Aissouni, L. (2003) Glutamate transport alteration triggers differentiation-state selective oxidative death of cultured astrocytes: a mechanism different from excitotoxicity depending on intracellular GSH contents. J. Neurochem., 85, 1159-1170.
47. Reichelt, W., Stabel-Burow, J., Pannicke, T., Weichert, H. & Heinemann, U. (1997) The glutathione level of retinal Muller glial cells is dependent on the high-affinity sodium-dependent uptake of glutamate. Neuroscience. 77, 1213-1224.
48. Rodriguez-Puertas, R., Herrera-Marschitz, M., Koistinaho, J. & Hokfelt, T. (1999) Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats. Neuroscience, 89, 781-797.
49. Salin, P., Manrique, C., Forni, C. & Kerkerian-Le Goff, L. (2002) High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J. Neurosci., 22, 5137-5148.
50. Schmidt, W.J. (1998) Dopamine-glutamate interactions in the basal ganglia. Amino Acids, 14, 5-10.
51. Timmerman, W. & Westerink, B.H. (1997) Brain microdialysis of GABA and glutamate: what does it signify? Synapse, 27, 242-261.